Explore more publications!

The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

Press releases published on January 13, 2026

AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
ClinNEXUS Appoints Jovan Hollins to Chief Operating Officer
IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
Picard / SynCardia Featured on the Cruxx of MedTech Podcast
Truveta launches Truveta Live Link
DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
DIAGNOS fait progresser sa stratégie réglementaire pour CARA sur les marchés clés : mises à jour sur les progrès réalisés auprès de Santé Canada, de la FDA et de la SFDA
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects 
Propanc Biopharma Provides Shareholder Update
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
LifeRx Formally Launches Nationwide ED & Hair Loss Treatment Programs After Strong Early Traction
NetraMark Announces Private Placement Financing
Pheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol Change
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
Evaxion expands AI-Immunology™ platform into autoimmune diseases

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions